Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data

Neuro-Oncology

Volumn 14, Issue 9, 2012, Pages 1171-1177

  Davis, Faith G ^a,b   Dolecek, Therese A ^c,d   McCarthy, Bridget J ^c,d   Villano, John L ^e  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Edmonton Clinic Health Academy   (Canada)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Central Brain Tumor Registry of the United States   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cancer incidence; Cancer surveillance; Metastatic brain tumors

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BRAIN METASTASIS; BREAST CANCER; BRONCHUS CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; ESOPHAGUS CANCER; ETHNICITY; FEMALE; HUMAN; KIDNEY CANCER; LIFESPAN; LIVER CANCER; LUNG CANCER; MALE; MELANOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PROSTATE CANCER; RISK ASSESSMENT; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; UNITED STATES; UTERUS CANCER;

AGE FACTORS; BRAIN NEOPLASMS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84867494866     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos152     Document Type: Article

References (38)

1. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am. 2009;22(1):1-6.
2. Silverberg E, Lubera JA. Cancer statistics. CA Cancer J Clin. 1989;39(1):3-20.
3. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol. 2005;75(1):5-14.
4. Nussbaum ES, Djalilian HR, Cho KH, Hall WA. Brain metastases: Histology, multiplicity, surgery, and survival. Cancer. 1996;78(8):1781-1788.
5. Smedby KE, Brandt L, Backlund ML, Blomqvist P. Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer. 2009;101(11):1919-1924.
6. Kalkanis SN, Kondziolka D, Gaspar LE, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):33-43.
7. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22(1):2865-2872.
8. Gore ME, Hariharan S, Porta C, et al. Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer. 2011;117(3):501-509.
9. Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model. Ann Oncol. 2002;13(7):1099-1107.
10. Mongan JP, Fadul CE, Cole BF, et al. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer. 2009;8(2):100-105.
11. Weinberg JS, Suki D, Hanbali F, Cohen ZR, Lenzi R, Sawaya R. Metastasis of esophageal carcinoma to the brain. Cancer. 2003;98(9):1925-1933.
12. International Germ Cell Consensus Classification: a prognostic factorbased staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol. 1997;15(2):594-603.
13. Anderson TS, Regine WF, Kryscio R, Patchell RA. Neurologic complications of bladder carcinoma: a review of 359 cases. Cancer. 2003;97(9):2267-2272.
14. Hjiyiannakis P, Jefferies S, Harmer CL. Brain metastases in patients with differentiated thyroid carcinoma. Clin Oncol (R Coll Radiol). 1996;8(5):327-330.
15. Choi HJ, Cho BC, Sohn JH, et al. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC. J Neurooncol. 2009;91(3):307-313.
16. York JE, Stringer J, Ajani JA, Wildrick DM, Gokaslan ZL. Gastric cancer and metastasis to the brain. Ann Surg Oncol. 1999;6(8):771-776.
17. Tremont-Lukats IW, Bobustuc G, Lagos GK, Lolas K, Kyritsis AP, Puduvalli VK. Brain metastasis from prostate carcinoma: The M. D. Anderson Cancer Center experience. Cancer. 2003;98(2):363-368.
18. Gien LT, Kwon JS, D'Souza DP, et al. Brain metastases from endometrial carcinoma: a retrospective study. Gynecol Oncol. 2004;93(2):524-528.
19. Kolomainen DF, Larkin JM, Badran M, et al. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20(4):982-986.
20. United States Cancer Statistics: 1999-2008 Incidence, WONDER Online Database. United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2011. Available at http://wonder.cdc.gov/cancerv2008.html. Accessed March 5, 2012.
21. *Stat Database: Incidence - SEER 9 Regs Research Data, Nov. 2010 Sub (1973-2008), Katrina/Rita Population Adjustment. - Linked To County Attributes - Total U. S., 1969-2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, 425 Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Accessed March 5, 2012.
22. Central Brain Tumor Registry of the US. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. 2012. Available at www.cbtrus.org. Accessed March 5, 2012.
23. Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357(7):664-672.
24. Paumier A, Le Pechoux C. Radiotherapy in small-cell lung cancer: where should it go? Lung Cancer. 2010;69(2):133-140.
25. Besse B, Massard C, Haddad V, et al. ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy. Ann Oncol. 2011;22(3):575-581.
26. Gaspar LE, Chansky K, Albain KS, et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol. 2005;23(13):2955-2961.
27. Gore EM, Bae K, Wong SJ, et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol. 2011;29(3):272-278.
28. Edelman MJ, Belani CP, Socinski MA, et al. Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. J Thorac Oncol. 2010;5(1):110-116.
29. Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higherdose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol. 2009;10(5):467-474.
30. Giuliani M, Sun A, Bezjak A, et al. Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. Cancer. 2010;116(24):5694-5699.
31. Go PH, Klaassen Z, Meadows MC, Chamberlain RS. Gastrointestinal cancer and brain metastasis: A rare and ominous sign. Cancer. 2011;117(16):3630-3640.
32. Massard C, Zonierek J, Gross-Goupil M, Fizazi K, Szczylik C, Escudier B. Incidence of brain metastases in renal cell carcinoma treated with sorafenib. Ann Oncol. 2010;21(5):1027-1031.
33. Rice TW, Khuntia D, Rybicki LA, et al. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Ann Thorac Surg. 2006;82(6):2042-2049, 2049.e1-2.
34. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94(10):2698-2705.
35. Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol. 2006;17(6):935-944.
36. Dawood S, Broglio K, Esteva FJ, et al. Survival among women with triple receptor-negative breast cancer and brain metastases. Ann Oncol. 2009;20(4):621-627.
37. Tham YL, Sexton K, Kramer R, Hilsenback S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006;107(4):696-704.
38. Gaspar LE, Mehta MP, Patchell RA, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010;96(1):17-32.